Skip to main content
Top
Published in: Diabetes Therapy 2/2019

Open Access 01-04-2019 | Mood Disorders | Original Research

Quality of Life is Markedly Impaired by Rheumatological and Skin Manifestations in Patients with Type 1 Diabetes: A Questionnaire Survey

Authors: Kirsten Nørgaard, Urd Kielgast

Published in: Diabetes Therapy | Issue 2/2019

Login to get access

Abstract

Introduction

To estimate lifetime prevalence of diabetes-related upper limb and non-acquired skin manifestations in a representative type 1 diabetes (T1D) population and to identify associations between these conditions and quality of life.

Methods

A questionnaire on these complications and measures of quality of life (World Health Organization–Five Well-Being Index [WHO-5]), depression, and diabetes-specific burden (Problem Areas in Diabetes [PAID] scale) was sent to all T1D patients in a Danish clinic (N = 583).

Results

The response rate was 68.6%. Lifetime prevalence of any upper limb soft tissue lesion was 72%; prevalence of any skin lesion was 10.5%. Frozen shoulder and vitiligo were most common upper limb and skin manifestation, at a prevalence of 53 and 9.1%, respectively. Compared to patients with no skin lesion, those with at least one skin lesion had more depression (19 vs. 33%; P < 0.01) and lower WHO-5 scores. Frozen shoulder was associated with lower WHO-5 scores (P < 0.001), more depression (29 vs. 14%; P < 0.001), and a higher PAID score (P < 0.01). A diagnosis of carpal tunnel syndrome was associated with lower WHO-5 scores (P < 0.001), a higher risk of depression (29 vs. 16%; P < 0.01), and a higher PAID score (P < 0.001).

Conclusion

Upper limb soft tissue lesions and diabetes-specific non-acquired skin lesions are very common in patients with T1D and strongly associated with impaired life quality and increased risk of depression.
Literature
1.
go back to reference Jacobson AM, Braffett BH, Cleary PA, Gubitosi-Klug RA, Larkin ME, The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. The long-term effects of type 1 diabetes treatment and complications on health-related quality of life. Diabetes Care. 2013;36:3131–8.CrossRef Jacobson AM, Braffett BH, Cleary PA, Gubitosi-Klug RA, Larkin ME, The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. The long-term effects of type 1 diabetes treatment and complications on health-related quality of life. Diabetes Care. 2013;36:3131–8.CrossRef
3.
go back to reference Arkkila PE, Kantola IM, Viikari JS, Rönnemaa T. Shoulder capsulitis in type I and II diabetic patients: association with diabetic complications and related diseases. Ann Rheum Dis. 1996;55:907–14.PubMedPubMedCentralCrossRef Arkkila PE, Kantola IM, Viikari JS, Rönnemaa T. Shoulder capsulitis in type I and II diabetic patients: association with diabetic complications and related diseases. Ann Rheum Dis. 1996;55:907–14.PubMedPubMedCentralCrossRef
4.
go back to reference Raje YR, Cracknell G, Davoren PM. Frequency of hand and shoulder symptoms in patients with Type 1 diabetes. Diabet Med. 2015;32:968–71.PubMedCrossRef Raje YR, Cracknell G, Davoren PM. Frequency of hand and shoulder symptoms in patients with Type 1 diabetes. Diabet Med. 2015;32:968–71.PubMedCrossRef
5.
go back to reference Gutefeldt K, Hedman CA, Thyberg ISM, Bachrach-Lindström M, Arnqvist HJ, Spångeus A (2017) Upper extremity impairments in type 1 diabetes with long duration; common problems with great impact on daily life. Disabil Rehabil 5:1–8. Gutefeldt K, Hedman CA, Thyberg ISM, Bachrach-Lindström M, Arnqvist HJ, Spångeus A (2017) Upper extremity impairments in type 1 diabetes with long duration; common problems with great impact on daily life. Disabil Rehabil 5:1–8.
6.
go back to reference Holte KB, Juel NG, Brox JI, et al. Hand, shoulder and back stiffness in long-term type 1 diabetes; cross-sectional association with skin collagen advanced glycation end-products. The Dialong study. J Diabetes Complications. 2017;31:1408–14.PubMedCrossRef Holte KB, Juel NG, Brox JI, et al. Hand, shoulder and back stiffness in long-term type 1 diabetes; cross-sectional association with skin collagen advanced glycation end-products. The Dialong study. J Diabetes Complications. 2017;31:1408–14.PubMedCrossRef
7.
go back to reference Juel NG, Brox JI, Brunborg C, Holte KB, Berg TJ. Very high prevalence of frozen shoulder in patients with type 1 diabetes of ≥ 45 years’ duration: the Dialong Shoulder Study. Arch Phys Med Rehabil. 2017;98:1551–9.PubMedCrossRef Juel NG, Brox JI, Brunborg C, Holte KB, Berg TJ. Very high prevalence of frozen shoulder in patients with type 1 diabetes of ≥ 45 years’ duration: the Dialong Shoulder Study. Arch Phys Med Rehabil. 2017;98:1551–9.PubMedCrossRef
8.
go back to reference Thomas SJ, McDougall C, Brown IDM, et al. Prevalence of symptoms and signs of shoulder problems in people with diabetes mellitus. J Shoulder Elb Surg. 2007;16:748–51.CrossRef Thomas SJ, McDougall C, Brown IDM, et al. Prevalence of symptoms and signs of shoulder problems in people with diabetes mellitus. J Shoulder Elb Surg. 2007;16:748–51.CrossRef
9.
go back to reference Ramchurn N, Mashamba C, Leitch E, et al. Upper limb musculoskeletal abnormalities and poor metabolic control in diabetes. Eur J Intern Med. 2009;20:718–21.PubMedCrossRef Ramchurn N, Mashamba C, Leitch E, et al. Upper limb musculoskeletal abnormalities and poor metabolic control in diabetes. Eur J Intern Med. 2009;20:718–21.PubMedCrossRef
11.
go back to reference De Macedo GMC, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabetol Metab Syndr. 2016;8:1–8.CrossRef De Macedo GMC, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabetol Metab Syndr. 2016;8:1–8.CrossRef
12.
go back to reference Lima AL, Illing T, Schliemann S, Elsner P. Cutaneous manifestations of diabetes mellitus: a review. Am J Clin Dermatol. 2017;18:541–53.PubMedCrossRef Lima AL, Illing T, Schliemann S, Elsner P. Cutaneous manifestations of diabetes mellitus: a review. Am J Clin Dermatol. 2017;18:541–53.PubMedCrossRef
13.
go back to reference Ovayolu N, Ovayolu O, Karadag G. Health-related quality of life in ankylosing spondylitis, fibromyalgia syndrome, and rheumatoid arthritis: a comparison with a selected sample of healthy individuals. Clin Rheumatol. 2011;30:655–64.PubMedCrossRef Ovayolu N, Ovayolu O, Karadag G. Health-related quality of life in ankylosing spondylitis, fibromyalgia syndrome, and rheumatoid arthritis: a comparison with a selected sample of healthy individuals. Clin Rheumatol. 2011;30:655–64.PubMedCrossRef
14.
go back to reference Misery L, Seneschal J, Reguiai Z, et al. Patient burden is associated with alterations in quality of life in adult patients with atopic dermatitis: results from the ECLA study. Acta Derm Venereol. 2018;98:713–4.PubMedCrossRef Misery L, Seneschal J, Reguiai Z, et al. Patient burden is associated with alterations in quality of life in adult patients with atopic dermatitis: results from the ECLA study. Acta Derm Venereol. 2018;98:713–4.PubMedCrossRef
15.
go back to reference Mahmutovic J, Zukic M, Pasalic A, Brankovic S, Jaganjac A, Katana B. Correlation between quality of life and depression among persons suffering from psoriasis. Med Arch. 2017;71:341–6.PubMedPubMedCentralCrossRef Mahmutovic J, Zukic M, Pasalic A, Brankovic S, Jaganjac A, Katana B. Correlation between quality of life and depression among persons suffering from psoriasis. Med Arch. 2017;71:341–6.PubMedPubMedCentralCrossRef
16.
go back to reference Topp CW, Østergaard SD, Søndergaard S, Bech P. The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015;84:167–76.PubMedCrossRef Topp CW, Østergaard SD, Søndergaard S, Bech P. The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015;84:167–76.PubMedCrossRef
17.
go back to reference Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18:754–60.PubMedCrossRef Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18:754–60.PubMedCrossRef
18.
go back to reference Singh R, Gamble G, Cundy T. Lifetime risk of symptomatic carpal tunnel syndrome in Type 1 diabetes. Diabet Med. 2005;22:625–30.PubMedCrossRef Singh R, Gamble G, Cundy T. Lifetime risk of symptomatic carpal tunnel syndrome in Type 1 diabetes. Diabet Med. 2005;22:625–30.PubMedCrossRef
19.
go back to reference Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus. A review. Endocrinol Metab Clin North Am. 2013;42:869–98.PubMedCrossRef Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus. A review. Endocrinol Metab Clin North Am. 2013;42:869–98.PubMedCrossRef
20.
go back to reference Hammer E, Lilienthal E, Hofer SE, Schulz S, Bollow E, Holl RW. Risk factors for necrobiosis lipoidica in Type 1 diabetes mellitus. Diabet Med. 2017;34:86–92.PubMedCrossRef Hammer E, Lilienthal E, Hofer SE, Schulz S, Bollow E, Holl RW. Risk factors for necrobiosis lipoidica in Type 1 diabetes mellitus. Diabet Med. 2017;34:86–92.PubMedCrossRef
21.
go back to reference Ezzedine K, Medicina D. Seminar vitiligo. Lancet. 2015;6736:1–11. Ezzedine K, Medicina D. Seminar vitiligo. Lancet. 2015;6736:1–11.
22.
go back to reference Talsania N, Lamb B, Bewley A. Vitiligo is more than skin deep: A survey of members of the Vitiligo Society. Clin Exp Dermatol. 2010;35:736–9.PubMedCrossRef Talsania N, Lamb B, Bewley A. Vitiligo is more than skin deep: A survey of members of the Vitiligo Society. Clin Exp Dermatol. 2010;35:736–9.PubMedCrossRef
23.
go back to reference Snoek FJ, Bremmer MA, Hermanns N. Constructs of depression and distress in diabetes: time for an appraisal. Lancet Diabetes Endocrinol. 2015;3:450–60.PubMedCrossRef Snoek FJ, Bremmer MA, Hermanns N. Constructs of depression and distress in diabetes: time for an appraisal. Lancet Diabetes Endocrinol. 2015;3:450–60.PubMedCrossRef
Metadata
Title
Quality of Life is Markedly Impaired by Rheumatological and Skin Manifestations in Patients with Type 1 Diabetes: A Questionnaire Survey
Authors
Kirsten Nørgaard
Urd Kielgast
Publication date
01-04-2019
Publisher
Springer Healthcare
Published in
Diabetes Therapy / Issue 2/2019
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-019-0587-5

Other articles of this Issue 2/2019

Diabetes Therapy 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine